Innovation
Synaptys Neuroscience: preventing Alzheimer’s disease with combination therapy
… candidate, the start-up went through four stages. The first was to identify the right molecules, which took two years. … they had to identify the correct receptor and, once this was done, the precise target or the right site to target on … initial discussions with pharmaceutical companies in order to carry out the final trials required and bring our …
Published on: